BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29614716)

  • 1. Immunization of Domestic Ducks with Live Nonpathogenic H5N3 Influenza Virus Prevents Shedding and Transmission of Highly Pathogenic H5N1 Virus to Chickens.
    Gambaryan A; Gordeychuk I; Boravleva E; Lomakina N; Kropotkina E; Lunitsin A; Klenk HD; Matrosovich M
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29614716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with live nonpathogenic H5N3 duck influenza virus protects chickens against highly pathogenic H5N1 virus.
    Gambaryan AS; Boravleva EY; Lomakina NF; Kropotkina EA; Gordeychuk IV; Chvala IA; Drygin VV; Klenk HD; Matrosovich MN
    Acta Virol; 2016; 60(3):316-27. PubMed ID: 27640442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.
    Zou Z; Hu Y; Liu Z; Zhong W; Cao H; Chen H; Jin M
    Vet Res; 2015 Apr; 46(1):42. PubMed ID: 25889564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens.
    Webster RG; Webby RJ; Hoffmann E; Rodenberg J; Kumar M; Chu HJ; Seiler P; Krauss S; Songserm T
    Virology; 2006 Aug; 351(2):303-11. PubMed ID: 16690097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks.
    Mundt E; Gay L; Jones L; Saavedra G; Tompkins SM; Tripp RA
    Arch Virol; 2009; 154(8):1241-8. PubMed ID: 19575275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Efficacy of the Inactivated H5N1 Influenza Vaccine Re-6 Against Different Clades of H5N1 Viruses Isolated in China and the Democratic People's Republic of Korea.
    Zeng X; Deng G; Liu L; Li Y; Shi J; Chen P; Feng H; Liu J; Guo X; Mao S; Yang F; Chen Z; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):238-40. PubMed ID: 27309061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens.
    Shichinohe S; Okamatsu M; Yamamoto N; Noda Y; Nomoto Y; Honda T; Takikawa N; Sakoda Y; Kida H
    Vet Microbiol; 2013 May; 164(1-2):39-45. PubMed ID: 23462521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.
    Shortridge KF; Zhou NN; Guan Y; Gao P; Ito T; Kawaoka Y; Kodihalli S; Krauss S; Markwell D; Murti KG; Norwood M; Senne D; Sims L; Takada A; Webster RG
    Virology; 1998 Dec; 252(2):331-42. PubMed ID: 9878612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus (HPAIV) from the 2021/22 epizootic is highly duck adapted and poorly adapted to chickens.
    James J; Billington E; Warren CJ; De Sliva D; Di Genova C; Airey M; Meyer SM; Lewis T; Peers-Dent J; Thomas SS; Lofts A; Furman N; Nunez A; Slomka MJ; Brown IH; Banyard AC
    J Gen Virol; 2023 May; 104(5):. PubMed ID: 37167079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.
    Middleton D; Bingham J; Selleck P; Lowther S; Gleeson L; Lehrbach P; Robinson S; Rodenberg J; Kumar M; Andrew M
    Virology; 2007 Mar; 359(1):66-71. PubMed ID: 17028058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
    Cha RM; Smith D; Shepherd E; Davis CT; Donis R; Nguyen T; Nguyen HD; Do HT; Inui K; Suarez DL; Swayne DE; Pantin-Jackwood M
    Vaccine; 2013 Oct; 31(43):4953-60. PubMed ID: 23994373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza.
    Lee YJ; Sung HW; Choi JG; Lee EK; Jeong OM; Kwon YK; Kwon JH; Song CS; Kimd JH
    Avian Dis; 2007 Mar; 51(1 Suppl):476-8. PubMed ID: 17494612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
    Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
    Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airborne Transmission of Highly Pathogenic Influenza Virus during Processing of Infected Poultry.
    Bertran K; Balzli C; Kwon YK; Tumpey TM; Clark A; Swayne DE
    Emerg Infect Dis; 2017 Nov; 23(11):1806-1814. PubMed ID: 29047426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.
    Liu M; Wood JM; Ellis T; Krauss S; Seiler P; Johnson C; Hoffmann E; Humberd J; Hulse D; Zhang Y; Webster RG; Perez DR
    Virology; 2003 Sep; 314(2):580-90. PubMed ID: 14554086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.